Merck Serono
FDA Gives Guardant Health IDE Approval for Clinical Trial of Merck KGaA Cancer Drug
Guardant is providing its Guardant 360 CDx test for a clinical trial of Merck's small molecule, c-Met kinase inhibitor called tepotinib.
Guardant is providing its Guardant 360 CDx test for a clinical trial of Merck's small molecule, c-Met kinase inhibitor called tepotinib.